All In MedTech

Device type · OHQ

Multi-Analyte Controls Unassayed

FDA groups similar devices under a three-letter product code. This page gathers what FDA's public data says about OHQ: how it is classified, what has been cleared or approved, and what has been reported and recalled.

Last checked: Nov 19, 2026Source: openFDAMethods & limitations

Product code

OHQ

Clinical Chemistry

Device class

Class I

FDA decisions since 2015

0

510(k), De Novo and PMA

Adverse event reports

0

Received Nov 1, 2025 to Nov 19, 2026

How FDA classifies it

Device type
Multi-Analyte Controls Unassayed
Product code
OHQ
Device class
Class I
Review panel
Clinical Chemistry
Regulation
21 CFR 862.1660

Latest FDA decisions

All decisions for OHQ

No 510(k), De Novo or PMA decisions for this product code since 2015.

Reports received

0

Received Nov 1, 2025 to Nov 19, 2026

Malfunction reports

0

Injury reports

0

Death reports

0

Adverse event reports received per month

By the date FDA received each report, stacked by event type. The newest month is incomplete.

Open in the MAUDE Monitor

No reports to chart for this view.

Manufacturers named most often

Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.

No manufacturers to rank.

Device problems as coded

Last 12 months. FDA's terms. A report can carry several.

No device problems coded.

Patient problems as coded

Last 12 months. FDA's terms. A report can carry several.

No patient problems coded.

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

  • TECHNO-PATH MANUFACTURING LTD.

    Z-0205-2027 · Started Aug 14, 2026 · Posted by FDA Oct 22, 2026

    Reason given: A routine stability studies have identified a stability drift affecting the Ammonia (NH4+) analyte in specific lots of Multichem AE quality control material. Additional testing confirmed that the labelled shelf-life performance claim for the Ammonia analyte can no longer be supported for the affected lots. This issue...

    Cause as FDA categorized it: Under Investigation by firm

  • TECHNO-PATH MANUFACTURING LTD.

    Z-0206-2027 · Started Aug 14, 2026 · Posted by FDA Oct 22, 2026

    Reason given: A routine stability studies have identified a stability drift affecting the Ammonia (NH4+) analyte in specific lots of Multichem AE quality control material. Additional testing confirmed that the labelled shelf-life performance claim for the Ammonia analyte can no longer be supported for the affected lots. This issue...

    Cause as FDA categorized it: Under Investigation by firm

  • TECHNO-PATH MANUFACTURING LTD.

    Z-0207-2027 · Started Aug 14, 2026 · Posted by FDA Oct 22, 2026

    Reason given: A routine stability studies have identified a stability drift affecting the Ammonia (NH4+) analyte in specific lots of Multichem AE quality control material. Additional testing confirmed that the labelled shelf-life performance claim for the Ammonia analyte can no longer be supported for the affected lots. This issue...

    Cause as FDA categorized it: Under Investigation by firm

24 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.